FDA Panel Overwhelmingly Backs Approval Of Anti-Obesity Pill A panel of advisers to the Food and Drug Administration overwhelmingly backed approval for a highly anticipated anti-obesity pill from Vivus Inc., a drug which the FDA previously rejected due to safety concerns.

More From CBS Philly

5 Phillies Players To Watch This Spring Training
Best Places To See Indie Rock In Philly
Restaurant Pairs Beers With Girl Scout Cookies

Listen Live